Literature DB >> 15021217

The role of diurnal pressure measurements in the management of open angle glaucoma.

Jacob T Wilensky1.   

Abstract

PURPOSE OF REVIEW: The measurement of intraocular pressure (IOP) is essential in the diagnosis and management of open-angle glaucoma, but a single measurement in the ophthalmologist's office may or may not reflect what the IOP is at other times of the day or night. It is well documented that the range of the daily fluctuations in IOP is greater in patients with glaucoma than in normal individuals, and a report by Asrani et al. suggested that the range of the diurnal fluctuation may be an independent risk factor for the progression of visual field loss. There have been reports of nocturnal increases in IOP, particularly in patients with normal tension glaucoma, and some ophthalmologists believe these may account for progression of visual field loss in some patients with glaucoma. This review will analyze recent articles that report the impact of various glaucoma therapies on the diurnal IOP curve and the use of diurnal curves in glaucoma diagnosis. RECENT
FINDINGS: A number of recent publications document that antiglaucoma medications with a long duration of action reduce the range of diurnal fluctuation more than the shorter duration medications. Laser trabeculoplasty and trabeculectomy also narrow the range of diurnal fluctuation, and at least one recent study finds that trabeculectomy reduces the diurnal range more than medical therapy does. Several recent studies of diurnal IOP in patients with glaucoma have failed to document such diurnal IOP spikes, so the published data available have not supported this hypothesis.
SUMMARY: One recent report has reconfirmed that a single IOP measurement in the office may not accurately indicate what is happening to the IOP of a patient with glaucoma throughout the day. Other reports have confirmed that treatment that lowers IOP narrows the range of diurnal IOP fluctuation, and one of these reports suggests that surgical reduction of IOL may narrow the fluctuation more than medical reduction of IOP. The reports of IOP during the night have not provided clear answers about what happens to IOP during sleep.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021217     DOI: 10.1097/00055735-200404000-00005

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  18 in total

1.  Static blood flow autoregulation in the optic nerve head in normal and experimental glaucoma.

Authors:  Lin Wang; Claude F Burgoyne; Grant Cull; Simon Thompson; Brad Fortune
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

2.  The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma.

Authors:  Kelly J Sigle; Gabriel Camaño-Garcia; Alicia L Carriquiry; Daniel M Betts; Markus H Kuehn; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2011-09       Impact factor: 1.644

3.  The amount of intraocular pressure rise during pharmacological pupillary dilatation is an indicator of the likelihood of future progression of glaucoma.

Authors:  Ghada A Siam; Daniela S Monteiro de Barros; Moataz E Gheith; Renata S Da Silva; Dara Lankaranian; Ethan H Tittler; Jonathan S Myers; George L Spaeth
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

4.  Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies.

Authors:  Jessica A Cooke; Jason S Meyer
Journal:  Curr Ophthalmol Rep       Date:  2015-08-07

5.  Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana).

Authors:  Guo Liu; Tao Zeng; Wenhan Yu; Naihong Yan; Hongxing Wang; Su-ping Cai; Iok-Hou Pang; Xuyang Liu
Journal:  Mol Vis       Date:  2011-05-27       Impact factor: 2.367

6.  Circadian intraocular pressure profiles in chronic open angle glaucomas.

Authors:  Jost B Jonas; Wido M Budde; Andrea Stroux; Isabel M Oberacher-Velten; Anselm G Juenemann
Journal:  J Ophthalmic Vis Res       Date:  2010-04

7.  The Influence of a Vitrectomy on the Diurnal Intraocular Pressure.

Authors:  Yong Woo Lee; Joon Mo Kim; Seong Hee Shim; Da Yeong Kim; Jeong Hun Bae; Ki Ho Park
Journal:  J Ophthalmol       Date:  2015-06-15       Impact factor: 1.909

8.  Review on Hypothetical Implementing TGF-β Family Members in Glaucoma Therapy.

Authors:  Ivan Sosa; Kata Culina; Alan Bosnar
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2012

Review 9.  24-h Efficacy of Glaucoma Treatment Options.

Authors:  Anastasios G P Konstas; Luciano Quaranta; Banu Bozkurt; Andreas Katsanos; Julian Garcia-Feijoo; Luca Rossetti; Tarek Shaarawy; Norbert Pfeiffer; Stefano Miglior
Journal:  Adv Ther       Date:  2016-02-24       Impact factor: 3.845

10.  Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management.

Authors:  Heidi Cate; Debi Bhattacharya; Allan Clark; Richard Fordham; Caitlin Notley; David C Broadway
Journal:  BMC Ophthalmol       Date:  2012-11-22       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.